On the other hand, GEM for instance reportedly exerts its cytotoxic effect on lung cancer cells through activation of JNK [45], suggesting the possibility that co-treatment could render the cells even more resistant to chemotherapeutic agents in case their cytotoxic effect is JNK-dependent. The gene discussed is MAPK8; the disease is lung carcinoma.